Orlando, FL -- (SBWIRE) -- 10/31/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Merrimack Pharmaceuticals Inc(NASDAQ:MACK), Glu Mobile Inc.(NASDAQ:GLUU), Prana Biotechnology Limited (ADR) (NASDAQ:PRAN).
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) shares declined 18.93% and closed at $2.74 in the last trading session. The company on Oct. 30 announced results of a global, Phase 2, open-label, randomized study of MM-121 in combination with paclitaxel versus paclitaxel alone in patients with platinum-resistant or platinum-refractory advanced ovarian cancers. This study did not meet the primary endpoint of progression free survival in the overall population. The hazard ratio (HR) for progression free survival (PFS) was 1.0 [95% CI 0.74 - 1.4].
Are investors worried about the recent updates with MACK? Find out with a free trend analysis HERE
Glu Mobile Inc.(NASDAQ:GLUU) shares fell 3.07% to $3.79. The company on Oct. 30 announced financial results for its third quarter ended September 30, 2013. Total GAAP revenues were $21.7 million in the third quarter of 2013 compared to $26.1 million in the third quarter of 2012. Total non-GAAP revenues were $22.6 million in the third quarter of 2013 compared to $25.9 million in the third quarter of 2012.
GAAP net loss was $(8.0) million for the third quarter of 2013 compared to a loss of $(3.6) million for the third quarter of 2012. GAAP EPS was a loss of $(0.11) for the third quarter of 2013, based on 71.5 million weighted-average basic shares outstanding, compared to a loss of $(0.06) for the third quarter of 2012, based on 64.6 million weighted-average basic shares outstanding.
Is GLUU going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares increased 19.89% to $4.40 in the last trading session. The company on Oct. 30 announced the publication of an article in the peer reviewed Aging Cell showing the effects of PBT2 on neurogenesis and in reversing the memory and learning losses associated with the aging process, in normal (ie non transgenic) old mice.
The paper, entitled "A Novel Approach To Rapidly Prevent Age-Related Cognitive Decline", appears in the journal Aging Cell available now online here*. The authors were led by Associate Professor Paul Adlard, Head, Synaptic Neurobiology Laboratory, The Florey Institute of Neuroscience and Mental Health.
Is PRAN going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)